Move will add surgical imaging system to product portfolio.
Carestream Health and Ziehm Imaging announced a partnership on April 19 that will add a mobile C-arm to the Carestream product portfolio.
The mobile C-arm, known as the Ziehm Vision RFD C-arm is a surgical imaging system that will expand Carestream’s mobile and fluoroscopic capabilities.
“The partnership with Carestream confirms Ziehm Imaging’s industry-leading technology,” said Nelson Mendes, president and chief executive officer of Orthoscan and Ziehm Imaging, Inc. “As a result of this partnership, we’re able to provide Carestream and its customers with one of the most innovate C-arms on the market.”
The Vision RFD C-arm is outfitted with a 25-kilowatt generator in either a 20.5 x 20.5 cm or 31 cm x 31 cm field-of-view flat-panel CMOS digital detector. Not only does it allow for general surgical applications, but it can also provide for vascular, cardiac, spine ortho-trauma, and pain management procedural work.
According to company officials, the product’s Advanced Active Cooling system can extend case times beyond what is possible with traditional air-cooled systems. Its graphical interface is intuitive and can reduce training times and increase productivity, they said. By using SmartDose, it also reduces exposure.
Vision RFD systems will be available in the United States and Canada this year with sale and service available through Carestream.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
Study: AI Bolsters Sensitivity for Pneumothorax on CXR and Significantly Reduces Reporting Time
October 30th 2024For clinically actionable pneumothorax, an artificial intelligence algorithm demonstrated a 93 percent AUC and a 96 percent specificity rate in a study involving chest X-rays from over 27,000 adults.